NeoGenomics Inc (NEO)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $2.07B
Last updated: Nov 17, 2026 at 11:06 AM ET
NeoGenomics Inc (NEO) Competitors
The companies most similar to NeoGenomics are Personalis (PSNL), Veracyte (VCYT) and Fulgent Genetics (FLGT). NeoGenomics trades at 228.9x earnings, against a median of 20.5x for the 5 of these companies with a P/E. By market cap, NeoGenomics ranks 7th of the 13 companies on this page; Qiagen NV (QGEN) is the largest at $10.30B.
Peer Comparison
NEO's ROIC of -2.5% is below the peer median of -1.3%, and its revenue growth of 11.4% is above the median of 11.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| NeoGenomics (NEO) | $2.07B | 228.9x | 2.6x | -4.1% | -2.5% | 11.4% | 0.00% |
| Personalis Inc (PSNL) | $1.70B | N/A | 20.9x | -147.7% | N/A | 76.6% | 0.00% |
| Veracyte Inc (VCYT) | $1.96B | 13.3x | 3.3x | 21.8% | 8.2% | 15.1% | 0.00% |
| Fulgent Genetics Inc (FLGT) | $688.98M | N/A | 2.0x | -27.5% | -12.1% | 7.5% | 0.00% |
| Opko Health Inc (OPK) | $1.25B | N/A | 2.4x | -22.6% | -6.2% | 15.9% | 0.00% |
| Castle Biosciences Inc (CSTL) | $1.04B | N/A | 2.7x | -6.1% | -5.4% | 23.9% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| Myriad Genetics Inc (MYGN) | $542.92M | N/A | 0.7x | -16.1% | -29.5% | -1.5% | 0.00% |
| RadNet Inc (RDNT) | $6.02B | 141.5x | 2.5x | -0.9% | 2.7% | 22.1% | 0.00% |
| Sotera Health Co (SHC) | $4.74B | 17.1x | 3.8x | 14.1% | 9.0% | 4.4% | 0.00% |
| Adaptive Biotechnologies Corp (ADPT) | $4.70B | N/A | 15.0x | -23.7% | N/A | -10.7% | 0.00% |
| Qiagen NV (QGEN) | $10.30B | 20.5x | 4.9x | 18.2% | 8.2% | 2.9% | 0.70% |
| Peer median | $3.03B | 20.5x | 3.6x | -11.1% | -1.3% | 11.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to NeoGenomics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Diagnostics & Research.
| Company | About | Peers |
|---|---|---|
| Personalis Inc (PSNL) | Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California. | PSNL competitors |
| Veracyte Inc (VCYT) | Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California. | VCYT competitors |
| Fulgent Genetics Inc (FLGT) | Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. | FLGT competitors |
| Opko Health Inc (OPK) | OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico... | OPK competitors |
| Castle Biosciences Inc (CSTL) | Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests... | CSTL competitors |
| GRAIL, LLC (GRAL) | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| CareDx Inc (CDNA) | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
| Myriad Genetics Inc (MYGN) | Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized... | MYGN competitors |
| RadNet Inc (RDNT) | RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California. | RDNT competitors |
| Sotera Health Co (SHC) | Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical... | SHC competitors |
| Adaptive Biotechnologies Corp (ADPT) | Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. | ADPT competitors |
| Qiagen NV (QGEN) | QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. | QGEN competitors |
Frequently Asked Questions About NEO
Who are NeoGenomics' main competitors?
The companies most similar to NeoGenomics include Personalis (PSNL), Veracyte (VCYT), Fulgent Genetics (FLGT), Opko Health (OPK) and Castle Biosciences (CSTL), listed from the closest match.
Who is NeoGenomics' biggest competitor?
Qiagen NV (QGEN) is the largest of the similar companies at $10.30B; Personalis (PSNL) is the closest match by business profile, size, sector and industry.
How does NEO stock compare with its competitors?
NEO's P/E is 228.9x against a peer median of 20.5x; its P/S is 2.6x against a peer median of 3.6x; its net margin is -4.1% against a peer median of -11.1%.
Which of NeoGenomics' competitors pays a higher dividend?
NeoGenomics pays no dividend. Qiagen NV (QGEN) has a higher forward dividend yield; Qiagen NV (QGEN) has the highest at 0.70%.
Is NeoGenomics bigger than its competitors?
No. NeoGenomics is 7th by market cap among the 13 companies on this page; the largest is Qiagen NV (QGEN) at $10.30B.
NEO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts